Loading stock data…
Moderna, Inc. (MRNA)
$69.70+2.43 (+3.61%)
After Hours$69.70+0.00 (+0.00%)· Last close Jun 29
Moderna, Inc., a biotechnology company, provides messenger RNA medicines in the United States, Europe, and internationally.
Historical Price
Price (Candle)
50-Day SMA
200-Day SMA
Whystock Brain
The Narrative
Moderna, Inc. in the Healthcare sector is trading at $69.70 with a market capitalization of $27.7B. Wall Street consensus targets $44.25 (20 analysts), implying a -36.5% move over the next 12 months. The stock is currently near its 52-week high of $69.90, remaining 72.7% above its 200-day moving average. On fundamentals, Piotroski 5/9 shows mixed financial quality, Altman Z in the safe zone. The Whystock Score of 65/100 suggests a balanced risk-reward profile.
Ecosystem Influences
Sell-side targets imply -36.5% downside over 12 months
Long-term trend bullish (price vs 200-day SMA)
Macro-economic sensitivity to interest rate and inflation shifts
Quarterly Financials
| Metric (USD) | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 |
|---|---|---|---|---|---|
| Total Revenue | $389.00M↓ | $676.00M↓ | $1.00B↑ | $137.00M↑ | $107.00M |
| Gross Profit | -$566.00M↓ | $224.00M↓ | $795.00M↑ | $18.00M↑ | $17.00M |
| Operating Income | -$1.39B↓ | -$857.00M↓ | -$260.00M↑ | -$907.00M↑ | -$1.05B |
| Net Income | -$1.34B↓ | -$826.00M↓ | -$200.00M↑ | -$825.00M↑ | -$971.00M |
Peer Comparison
JNJUNHPFE
Fundamentals
Moderna, Inc., a biotechnology company, provides messenger RNA medicines in the United States, Europe, and internationally. The company's respiratory vaccines include spikevax, mNEXSPIKE, mRESVIA, COVID, RSV, seasonal influenza, combination, and pand...
Market Cap
Total dollar market value of a company's outstanding shares of stock (Price * Shares).
$27.66B
P/E Ratio
Priced for growth. Investors expect sustained double-digit expansion.
-
Beta
High-beta play. Expect amplified moves vs. the broad market.
1.03
Div Yield
Low to zero yield. Return is entirely dependent on price appreciation.
0.00%
ROE
Average efficiency. Growth may require heavy reinvestment.
-43.12%
Volume
Today's trading volume
7.92M
Recent News
Stocks Rally to Start a Big Holiday Week: Stock Market Today
Comcast created a stir among communication services stocks with a plan to spin off its media and entertainment assets into a new publicly traded company.
MRNA Stock Jumps to 52-Week High on Expansion Plans Beyond Vaccines
Moderna hit a 52-week high after it unveiled a strategy to expand its mRNA platform beyond vaccines into oncology, autoimmune diseases and AI-driven R&D.
MRNA Stock Spikes as Moderna Shares mRNA Pipeline Update
Moderna stock soars on positive updates during the Science Day presentation. Jefferies sees significant further upside in MRNA shares.
US Stock Market Today: S&P 500 Futures Slip As Sticky Inflation Keeps Fed Cautious
The Morning Bull - US Market Morning Update Monday, Jun, 29 2026 US stock futures are pointing lower this morning, with E-mini S&P 500 contracts down about 0.3% and Nasdaq-100 futures weaker by roughly 1.2%, as investors weigh solid US spending against stubborn inflation. Core PCE inflation sits at 3.4% year over year, which means the cost of living is still rising faster than the Federal Reserve would like, while real personal spending grew 0.3% and incomes rose 0.7% in May. This suggests...
This COVID Stock Market Winner Is Making a Comeback, Up 125% Year to Date
Moderna stock is up 125.51% in 2026, driven by an FDA flu vaccine win, a corporate pivot, and an expanding pipeline.